Get access

Outcomes following resection of pancreatic cancer

Authors

  • Elan R. Witkowski MD, SM,

    1. Surgical Outcomes Analysis & Research (SOAR), University of Massachusetts Medical School, Worcester, Massachusetts
    Search for more papers by this author
  • Jillian K. Smith MD, MPH,

    1. Surgical Outcomes Analysis & Research (SOAR), University of Massachusetts Medical School, Worcester, Massachusetts
    Search for more papers by this author
  • Jennifer F. Tseng MD, MPH

    Corresponding author
    1. Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • Chief, Division of Surgical Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Stoneman 9, Boston, MA 02215. Fax: +617-667-7756.===

    Search for more papers by this author

Abstract

Pancreatic cancer is an aggressive and highly lethal malignancy. Surgical resection is a modest tool, but it provides the only potential for curative therapy and often prolongs survival. This article reviews the progress made on both local and national levels towards an era of safer pancreatic surgery, while discussing both perioperative outcomes and long-term survival after resection. J. Surg. Oncol. 2013;107:97–103. © 2012 Wiley Periodicals, Inc.

Ancillary